Norden Group’s Bristol-Myers Squibb BMY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $911K | Sell |
19,686
-73,134
| -79% | -$3.39M | 0.1% | 202 |
|
|
2025
Q1 | $5.66M | Buy |
92,820
+744
| +0.8% | +$45.4K | 0.65% | 27 |
|
|
2024
Q4 | $5.21M | Buy |
92,076
+70,423
| +325% | +$3.98M | 0.59% | 33 |
|
|
2024
Q3 | $1.12M | Buy |
21,653
+11,158
| +106% | +$577K | 0.13% | 170 |
|
|
2024
Q2 | $436K | Sell |
10,495
-3,351
| -24% | -$139K | 0.09% | 240 |
|
|
2024
Q1 | $751K | Buy |
13,846
+3,213
| +30% | +$174K | 0.15% | 153 |
|
|
2023
Q4 | $546K | Buy |
10,633
+773
| +8% | +$39.7K | 0.09% | 137 |
|
|
2023
Q3 | $572K | Buy |
+9,860
| New | +$572K | 0.19% | 121 |
|